Dare Bioscience, Inc. Debt Conversion, Original Debt, Amount
Dare Bioscience, Inc. (DARE) reported Debt Conversion, Original Debt, Amount of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2019-04-01
- Dare Bioscience, Inc. debt conversion, original debt, amount for the quarter ending 2014-12-31 was $1.00K.
- Dare Bioscience, Inc. debt conversion, original debt, amount for the quarter ending 2014-09-30 was -$10.00K.
- Dare Bioscience, Inc. debt conversion, original debt, amount for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Dare Bioscience, Inc. debt conversion, original debt, amount for fiscal 2017 was $912.96K.
- Dare Bioscience, Inc. debt conversion, original debt, amount for fiscal 2014 was $20.13M.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-04-01 | |||
| 2017-12-31 | $912.96K 10-K · filed 2019-04-01 | |||
| 2014-12-31 | $1.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | -$9.00K derived: sum of 2 quarters · filed 2017-06-13 | $20.13M 10-K/A · filed 2017-06-13 | |
| 2014-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $20.13M 10-Q · filed 2015-11-16 | ||
| 2014-06-30 | $20.14M 10-Q · filed 2015-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |